Camilla C Golfeto, Gustavo Von Poelhsitz, Heloísa S Selistre-de-Araújo, Márcio P de Araujo, Javier Ellena, Eduardo E Castellano, Luiz G L Lopes, Icaro S Moreira, Alzir A Batista
Index: J. Inorg. Biochem. 104(5) , 489-95, (2010)
Full Text: HTML
The synthesis and characterization of ruthenium compounds of the type [RuCl(2)(NO)(dppp)(L)]PF(6) [dppp=1,3-bis(diphenylphosphino)propane; L=pyridine, 4-methylpyridine, 4-phenylpyridine and dimethyl sulfoxide] are described. The complexes were characterized by elemental analysis, UV/Vis and infrared spectroscopy, cyclic voltammetry, and X-ray crystallography for the complexes with the pyridine and 4-methylpyridine ligands. In vitro evaluation of these nitrosyl complexes revealed cytotoxic activity from 7.1 to 19.0 microM against the MDA-MB-231 breast tumor cells and showed that, in this case, they are more active than the reference metallodrug cisplatin. The 1,3-bis(diphenylphosphino)propane and the N-heterocyclic ligands alone failed to show cytotoxic activities at the concentrations tested (maximum concentration utilized=200 microM).
Structure | Name/CAS No. | Molecular Formula | Articles |
---|---|---|---|
![]() |
4-Phenylpyridine
CAS:939-23-1 |
C11H9N |
cIEF for rapid pKa determination of small molecules: a proof...
2014-10-15 [Eur. J. Pharm. Sci. 63 , 14-21, (2014)] |
Calculating virtual log P in the alkane/water system (log P(...
2005-05-05 [J. Med. Chem. 48 , 3269-79, (2005)] |
4-phenylpyridine and three other analogues of 1-methyl-4-phe...
1987-03-20 [Neurosci. Lett. 75(1) , 65-70, (1987)] |
Simple chip-based interfaces for on-line monitoring of supra...
2005-10-01 [Lab Chip 5(10) , 1111-22, (2005)] |
Potentiation of MPTP by 4-phenylpyridine on the neuromuscula...
1993-09-01 [Neuropharmacology 32(9) , 877-83, (1993)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved